Protein Hydrolysates and Bioactive Peptides as Mediators of Blood Glucose—A Systematic Review and Meta-Analysis of Acute and Long-Term Studies

Arig Elbira,Maryam Hafiz,Alan Javier Hernández-Álvarez,Michael A. Zulyniak,Christine Boesch
DOI: https://doi.org/10.3390/nu16020323
IF: 5.9
2024-01-23
Nutrients
Abstract:Type 2 diabetes mellitus (T2DM) is a major public health concern associated with high mortality and reduced life expectancy. Since diabetes is closely linked with lifestyle, not surprisingly, nutritional intervention and increased physical activity could play a vital role in attenuating the problems related to diabetes. Protein hydrolysates (PHs) and their bioactive peptides (BP) have been shown to exert a wide range of biological effects, including antioxidative, antihypertensive, and in particular, hypoglycaemic activities. To better understand the efficacy of such interventions, a systematic review and meta-analysis of randomised controlled trials (RCTs) were performed concerning the influence of protein hydrolysates on glycaemic biomarkers in subjects with and without hyperglycaemia. Five different databases were used to search for RCTs. In total, 37 RCTs were included in the systematic review and 29 RCTs in the meta-analysis. The meta-analysis revealed a significant reduction in postprandial blood glucose response (PPGR) in normoglycaemic (−0.22 mmol/L; 95% CI −0.43, −0.01; p ≤ 0.05) and in hyperglycaemic adults (−0.88 mmol/L; 95% CI −1.37, −0.39; p ≤ 0.001) compared with the respective control groups. A meta-regression analysis revealed a dose-dependent response for PPGR following PH consumption in normoglycaemic adults, specifically for doses ≤ 30 g. The postprandial blood insulin responses (PPIR) were significantly higher after the ingestion of PHs in both the group with and the group without hyperglycaemia, respectively (23.05 mIU/L; 95% CI 7.53, 38.57; p ≤ 0.01 and 12.57 mIU/L; 95% CI 2.72, 22.41; p ≤ 0.01), compared with controls. In terms of long-term responses, there was a small but significant reduction in both fasting blood glucose (FBG) and fasting glycated haemoglobin (HbA1c) in response to PH compared with the control group (p < 0.05). The PHs significantly improved the parameters of glycaemia in adults and, hence, it may contribute to the management and regulation of the future risk of developing T2DM.
nutrition & dietetics
What problem does this paper attempt to address?
The problem this paper attempts to address is the exploration of the effects of protein hydrolysates (PHs) and their bioactive peptides (BPs) on glycemic regulation, particularly their impact on glycemic markers in both acute (postprandial) and long-term studies. Specifically, the study aims to evaluate the hypoglycemic effects of protein hydrolysates in individuals with normal glycemia and hyperglycemia, and whether these effects are dose-dependent. Additionally, the study seeks to summarize existing evidence through systematic review and meta-analysis, identify differences between studies, determine effective doses and conditions, and thus support the development of functional products. ### Main Research Questions: 1. **Effects of Protein Hydrolysates and Bioactive Peptides on Glycemic Regulation**: Evaluate the hypoglycemic effects of protein hydrolysates and their bioactive peptides in individuals with normal glycemia and hyperglycemia. 2. **Dose-Dependence**: Investigate the relationship between the dose of protein hydrolysates and glycemic response. 3. **Long-Term Effects**: Assess the effects of protein hydrolysates in long-term interventions, particularly changes in fasting blood glucose and glycated hemoglobin (HbA1c). 4. **Mechanism Studies**: Explore the mechanisms through which protein hydrolysates and bioactive peptides affect glycemic regulation, such as inhibition of digestive enzymes like α-glucosidase and α-amylase. ### Research Background: - **Type 2 Diabetes Mellitus (T2DM)**: A chronic metabolic disorder with a high global prevalence, closely related to lifestyle. Nutritional interventions and increased physical activity may help alleviate diabetes-related issues. - **Limitations of Existing Medications**: Common hypoglycemic drugs such as α-glucosidase inhibitors and GLP-1 receptor agonists are effective but have side effects like gastrointestinal discomfort and renal damage. - **Demand for Natural Antidiabetic Agents**: In recent years, there has been growing interest in natural, safe, and low-side-effect food-derived antidiabetic agents. ### Research Methods: - **Systematic Review and Meta-Analysis**: Using systematic review and meta-analysis to synthesize results from multiple randomized controlled trials (RCTs) to evaluate the effects of protein hydrolysates on glycemic regulation. - **Data Sources**: Relevant literature was retrieved from PubMed, Web of Science, Scopus, ScienceDirect, and Cochrane databases. - **Study Selection Criteria**: Included randomized controlled trials in adult human populations evaluating the effects of food-derived bioactive peptides and protein hydrolysates on glycemia. - **Data Analysis**: Meta-analysis using a random-effects model to assess the impact of protein hydrolysates on postprandial glycemic response (PPGR) and postprandial insulin response (PPIR). ### Results: - **Acute Studies**: Protein hydrolysates significantly reduced postprandial glycemic response in individuals with normal glycemia and hyperglycemia (−0.22 mmol/L and −0.88 mmol/L, respectively), with the most significant effect observed at doses of 21-30 g in individuals with normal glycemia. - **Long-Term Studies**: Protein hydrolysates significantly improved fasting blood glucose and glycated hemoglobin (HbA1c) levels. ### Conclusion: Protein hydrolysates and their bioactive peptides have potential applications in glycemic control, particularly showing significant hypoglycemic effects in acute interventions. These findings provide scientific evidence for the development of new functional foods and therapeutic strategies.